Press Release FlowAid Medical Technologies Corp. Announced Positive Results from a Study of Patients with Diabetic Peripheral Neuropathy
A New Look at a Therapeutic Treatment for Diabetic Peripheral Neuropathy (DPN)
December 05, 2016 08:00 AM Eastern Standard Time
Flowaid Medical Technologies Inc. is pleased to open enrollment in a clinical trial of their Flowaid FA-100 SCCD. If you suffer from Painful Diabetic Peripheral Neuropathy and are interested in learning more; please contact us. The investigative device is a non-invasive electric muscle pump that attaches to the lower leg.
FlowAid Medical Technologies Inc. is pleased to announce the opening of enrollment in a clinical trial of its FlowAid FA100 SCCD in the New York Tri-State area. If you suffer from Painful Diabetic Peripheral Neuropathy (DPN), are interested in learning more and participating in this study, please contact us at (see file)
The FA100 device is a portable noninvasive electric muscle pump. The device is meant for daily home use, and does not interfere with any activities or schedule. The trial will last one month and requires an introductory visit, as well as one closing visit, with the principal investigators.
No medications are being evaluated as part of this study.
To find out more information about the device or read some of the published Medical Journal articles written about the device, please visit (see file)